Reid Adler, J.D. joined vistagen as our General Counsel in May 2022 after serving as outside counsel for several years, and he recently also became the head of business development. During his extensive career in the biopharma sector, Mr. Adler was a senior partner at two international law firms, Morrison & Foerster and Morgan Lewis, and the general counsel to the pioneering J. Craig Venter Institute for genomics research. While in private practice before joining Vistagen, he consulted with several major biopharmaceutical companies on product exclusivity and for the Coalition for Epidemic Preparedness Innovations (CEPI) on legal and business aspects of vaccine development. Earlier, he was the founding director of the NIH Office of Technology Transfer, which facilitated the translation of tax-payer-funded research results into healthcare products.
Mr. Adler received a Bachelor of Science degree from the University of Maryland, College Park, and a Juris Doctor degree from George Washington University. He has testified before the U.S. Congress, published widely, and taught graduate courses about innovation management, strategic planning, and biotechnology law and policy. At NIH, he played a key role in expanding relationships with industry, developing technology-related policies and model contractual agreements, research integrity guidelines, and the Uniform Biological Material Transfer Agreement, currently used by hundreds of organizations worldwide.